These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15748579)

  • 61. Acropustulosis repens.
    Proença NG
    Int J Dermatol; 2006 Apr; 45(4):389-93. PubMed ID: 16650164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy.
    Tadiotto Cicogna G; Messina F; Nalotto L; Szekely S; Alaibac M
    F1000Res; 2019; 8():336. PubMed ID: 31448100
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pustular Psoriasis: From Pathophysiology to Treatment.
    Genovese G; Moltrasio C; Cassano N; Maronese CA; Vena GA; Marzano AV
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944562
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Normal proliferative responses of peripheral blood mononuclear cells to streptococcal preparation OK-432 in patients with pustulosis palmaris et plantaris constitute a distinct feature from the reduced responses observed in those with psoriasis vulgaris, pustular psoriasis, and acrodermatitis continua of Hallopeau.
    Takahashi K; Aiba S; Uddin Z; Kasai H; Tagami H
    J Dermatol Sci; 2001 Jan; 25(1):87-92. PubMed ID: 11154870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acrodermatitis continua of Hallopeau--a report of a case.
    Rokiah Ismail ; Chan SP
    Med J Malaysia; 1983 Sep; 38(3):191-3. PubMed ID: 6672560
    [No Abstract]   [Full Text] [Related]  

  • 66. Benefit of gluten-free diet in acrodermatitis continua of Hallopeau associated with celiac disease: a case report.
    Fabre C; Lefèvre M; Dandurand M; Meunier L; Stoebner PE
    Int J Dermatol; 2014 Jul; 53(7):897-8. PubMed ID: 23489102
    [No Abstract]   [Full Text] [Related]  

  • 67. Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis.
    Frew JW; Murrell DF
    Skin Appendage Disord; 2017 Oct; 3(4):179-181. PubMed ID: 29177142
    [No Abstract]   [Full Text] [Related]  

  • 68. Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau.
    Rizzetto G; Diotallevi F; Molinelli E; Radi G; Offidani AM
    Skin Appendage Disord; 2022 Mar; 8(2):146-149. PubMed ID: 35419415
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Impetigo herpetiformis; acrodermatitis continua of Hallopeau and pustular psoriasis; etiology and pathogenesis and differential diagnosis].
    GRANELLI U
    Minerva Dermatol; 1956 Apr; 31(4):120-6. PubMed ID: 13348185
    [No Abstract]   [Full Text] [Related]  

  • 70. Algodystrophy (reflex sympathetic dystrophy) complicating unilateral acrodermatitis continua.
    Stephens CJ; McGibbon DH
    Clin Exp Dermatol; 1989 Nov; 14(6):445-7. PubMed ID: 2605810
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recalcitrant acrodermatitis continua of hallopeau treated with calcitriol and tacrolimus 0.1% topical treatment.
    Brunasso AM; Lo Scocco G; Massone C
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1272-3. PubMed ID: 18422537
    [No Abstract]   [Full Text] [Related]  

  • 72. Acrodermatitis continua of Hallopeau appearing at specific, high leucocyte counts.
    Kurooka S; Tsuruta D; Hino M; Yanagihara S; Ishii M
    Br J Dermatol; 2010 Aug; 163(2):428-30. PubMed ID: 20377584
    [No Abstract]   [Full Text] [Related]  

  • 73. Acquired acrodermatitis enteropathica: case report of an atypical presentation.
    Sanchez JE; Barham KL; Sangueza OP
    J Cutan Pathol; 2007 Jun; 34(6):490-3. PubMed ID: 17518778
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
    Adişen E; Oztaş M; Gürer MA
    Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
    [No Abstract]   [Full Text] [Related]  

  • 75. Dermatitis repens, Lapière and generalized pustular psoriasis.
    Colver GB; Burge SM; Millard PR; Ryan TJ
    Br J Dermatol; 1985 Nov; 113(5):623-8. PubMed ID: 4063196
    [TBL] [Abstract][Full Text] [Related]  

  • 76. European consensus statement on phenotypes of pustular psoriasis.
    Navarini AA; Burden AD; Capon F; Mrowietz U; Puig L; Köks S; Kingo K; Smith C; Barker JN;
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1792-1799. PubMed ID: 28585342
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acrodermatitis continua of Hallopeau with dense infiltration of IgG4-positive cells in the lesional dermis.
    Ogawa-Momohara M; Muro Y; Nakaguro M; Takeichi T; Kono M; Akiyama M
    Br J Dermatol; 2019 Apr; 180(4):941-942. PubMed ID: 30411319
    [No Abstract]   [Full Text] [Related]  

  • 78. Three years' experience with infliximab in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Clin Exp Dermatol; 2006 Sep; 31(5):630-3. PubMed ID: 16901301
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Squamous cell carcinoma mimicking acrodermatitis continua suppurativa in a patient with generalized pustular psoriasis.
    Balestri R; Magnano M; Ioris T; Girardelli CR; Rech G
    J Dtsch Dermatol Ges; 2023 May; 21(5):537-539. PubMed ID: 36960854
    [No Abstract]   [Full Text] [Related]  

  • 80. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.